Abstract
Background Metabolomics, defined as the comprehensive identification and quantification of low-molecular-weight
metabolites to be found in a biological sample, has been put forward as a potential tool for classifying individuals according to
their risk of coronary heart disease (CHD). Here, we investigated whether a single-point blood measurement of the metabolome
is associated with and predictive for the risk of CHD.
Original language | English |
---|---|
Pages (from-to) | 45-52.e7 |
Journal | American Heart Journal |
Volume | 168 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2014 |
Keywords
- artery-disease
- cardiovascular events
- population
- prediction
- plasma
- phosphatidylcholine
- metabonomics
- netherlands
- mortality
- cohort